Patent Assignment
Reel/Frame 064286/0472
Release of Security Interest
Recorded: 2023-07-17
Pages: 66
Assignor
HERCULES CAPITAL, INC.
Executed: 2023-07-11
Assignees
IVERIC BIO, INC.
8 SYLVAN WAY, PARSIPPANY, NEW JERSEY, 07054
IVERIC BIO GENE THERAPY LLC
8 SYLVAN WAY, PARSIPPANY, NEW JERSEY, 07054
ORION OPHTHALMOLOGY LLC
8 SYLVAN WAY, PARSIPPANY, NEW JERSEY, 07054
Covered Properties
(28)
Methods for Treating or Preventing Ophthalmological Conditions
Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
A Method for Treating or Preventing Idiopathic Polypoidal Choroidal Vasculopathy (Ipcv)
Carbocyclic Prolinamide Derivatives
Heterocyclic Prolinamide Derivatives
Application:
17/738,872 →
Publication:
US 2022/0267306
Anti-C5 Agent for Treatment of Dry Age-Related Macular Degeneration (Amd) or Geographic Atrophy Secondary to Dry Amd
Application:
17/772,291 →
Publication:
US 2022/0370629
Methods for Treating Ophthalmological Conditions
Application:
63/257,565 →
Sustained Release Silica Hydrogel Composites for Treating Ophthalmological Conditions and Methods of Using Same
Application:
63/357,631 →
Aav Vectors for Treatment of Dominant Retinitis Pigmentosa
Application:
17/327,609 →
Publication:
US 2021/0324387
Compositions and Methods for Treatment of Dominant Retinitis Pigmentosa
Minigene Therapy
Minigene Therapy
Gene Therapies for Usher Syndrome (USH2A)
Application:
17/604,545 →
Publication:
US 2022/0202959
Gene Therapies for Stargardt Disease (ABCA4)
Adeno-Associated Viral Vectors for the Treatment of Best Disease
Application:
17/272,203 →
Publication:
US 2022/0033826
Methods for Treating or Preventing Ophthalmological Conditions
Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
Carbocyclic Prolinamide Derivatives
Carbocyclic Prolinamide Derivatives
Heterocyclic Prolinamide Derivatives
Aliphatic Prolinamide Derivatives
Aav Vectors for Treatment of Dominant Retinitis Pigmentosa
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 30, 2005
From: BENEDICT, CLAUDE; DIENER, JOHN; EPSTEIN, DAVID; GRATE, DILARA
To: ARCHEMIX CORPORATION
Reel/Frame 017043/0556 →
Assignment of Assignor's Interest
Aug 26, 2008
From: BENEDICT, CLAUDE; EPSTEIN, DAVID; WILSON, CHARLES; MCCAULEY, DILARA
To: ARCHEMIX CORP
Reel/Frame 021443/0873 →
Assignment of Assignor's Interest
Mar 30, 2009
From: BENEDICT, CLAUDE; DIENER, JOHN; EPSTEIN, DAVID; GRATE, DILARA
To: ARCHEMIX CORP.
Reel/Frame 022467/0130 →
Assignment of Assignor's Interest
Jun 8, 2009
From: BENEDICT, CLAUDE; EPSTEIN, DAVID; KURZ, JEFFREY; KURZ, MARKUS
To: ARCHEMIX CORP.
Reel/Frame 022792/0053 →
Merger
Jan 10, 2012
From: ARCHEMIX CORP.
To: ARCHEMIX LLC
Reel/Frame 027510/0478 →
Assignment of Assignor's Interest
Nov 15, 2019
From: GAO, GUANGPING; KHANNA, HEMANT
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 051015/0787 →
Assignment of Assignor's Interest
Dec 16, 2020
From: REZAEI, KOUROUS
To: IVERIC BIO, INC.
Reel/Frame 054673/0706 →
Assignment of Assignor's Interest
Mar 5, 2021
From: LEWIN, ALFRED S.; HAUSWIRTH, WILLIAM W.; MASSENGILL, MICHAEL T.
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Reel/Frame 055509/0726 →
Assignment of Assignor's Interest
Mar 19, 2021
From: BELTRAN, WILLIAM; AGUIRRE, GUSTAVO D.; JACOBSON, SAMUEL; CIDECIYAN, ARTUR
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 055652/0633 →
Assignment of Assignor's Interest
May 30, 2021
From: HAUSWIRTH, WILLIAM W.; LEWIN, ALFRED S.; ILDEFONSO, CRISTHIAN J.; YOUNG, BRIANNA M.
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Reel/Frame 056390/0414 →
Assignment of Assignor's Interest
Jul 15, 2021
From: INCEPTION SCIENCES, INC.
To: INCEPTION 4, INC.
Reel/Frame 056862/0103 →
Merger
Jul 15, 2021
From: INCEPTION 4, INC.
To: ORION OPHTHALMOLOGY LLC
Reel/Frame 056862/0325 →
Assignment of Assignor's Interest
Jul 15, 2021
From: GOMEZ, ROBERT; DING, JINYUE; OBALLA, RENATA MARCELLA; POWELL, DAVID ANDREW
To: INCEPTION SCIENCES, INC.
Reel/Frame 056861/0855 →
Assignment of Assignor's Interest
Aug 25, 2021
From: LEWIN, ALFRED S.; HAUSWIRTH, WILLIAM W.; MASSENGILL, MICHAEL T.
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Reel/Frame 057280/0571 →
Assignment of Assignor's Interest
Aug 25, 2021
From: BELTRAN, WILLIAM; AGUIRRE, GUSTAVO D.; CIDECIYAN, ARTUR; JACOBSON, SAMUEL
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 057280/0541 →
Change of Name
Feb 1, 2022
From: OPHTHOTECH CORPORATION
To: IVERIC BIO, INC.
Reel/Frame 058955/0089 →
Assignment of Assignor's Interest
Feb 1, 2022
From: PATEL, SAMIR; EVERETT, RICHARD; BROOKS, DOUGLAS; TIAN, SHANE XINXIN
To: OPHTHOTECH CORPORATION
Reel/Frame 058851/0869 →
Assignment of Assignor's Interest
Mar 15, 2022
From: KHANNA, HEMANT
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 059262/0761 →
Assignment of Assignor's Interest
Mar 15, 2022
From: GAO, GUANGPING; KHANNA, HEMANT
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 059262/0927 →
Assignment of Assignor's Interest
Mar 15, 2022
From: KHANNA, HEMANT
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 059262/0857 →
Merger
May 6, 2022
From: INCEPTION 4, INC.
To: ORION OPHTHALMOLOGY LLC
Reel/Frame 059864/0188 →
Assignment of Assignor's Interest
May 6, 2022
From: GOMEZ, ROBERT; DING, JINYUE; OBALLA, RENATA MARCELLA; POWELL, DAVID ANDREW
To: INCEPTION SCIENCES, INC.
Reel/Frame 059864/0025 →
Assignment of Assignor's Interest
May 6, 2022
From: INCEPTION SCIENCES, INC.
To: INCEPTION 4, INC.
Reel/Frame 059864/0100 →
Security Interest
Aug 5, 2022
From: IVERIC BIO, INC.
To: HERCULES CAPITAL, INC.
Reel/Frame 061088/0048 →
Assignment of Assignor's Interest
Apr 27, 2023
From: REZAEI, KOUROUS A.
To: IVERIC BIO, INC.
Reel/Frame 063463/0050 →